Drug factory · FDA FEI 3006254924

CTX Lifesciences Pvt. Ltd.

251-252, Sachin Magdalla Road, GIDC Sachin, , Surat, India

India: 1

Problems found, fixed voluntarily at FDA's last inspection, Sep 2, 2022.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2009: 0 with no problems, 4 with problems fixed voluntarily, 1 with FDA action.

What it does, for whom

DrugRoleForNDC
MetoprololMakes the active ingredient Cipla USA., Inc. 69097-407, 69097-408, 69097-409

FDA inspection history

EndedResultProgramProblems noted
Sep 2, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 30, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 19, 2016Serious problems, FDA actionDrug Quality Assurance—
Dec 30, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 6, 2009Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: api manufacture.